Notice2023-04044
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 28, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) announce the following meeting for the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC). This meeting is open to the public, limited only by the number of audio and web conference lines (1,000 audio and web conference lines are available). Members of the public are welcome to listen to the meeting by accessing the telephone number and web access provided in the addresses section below. Time will be available for public comment (registration is required to provide oral comment).
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 39 (Tuesday, February 28, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 39 (Tuesday, February 28, 2023)]
[Notices]
[Page 12684]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-04044]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) and the Health Resources and
Services Administration (HRSA) announce the following meeting for the
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention
and Treatment (CHAC). This meeting is open to the public, limited only
by the number of audio and web conference lines (1,000 audio and web
conference lines are available). Members of the public are welcome to
listen to the meeting by accessing the telephone number and web access
provided in the addresses section below. Time will be available for
public comment (registration is required to provide oral comment).
DATES: The meeting will be held on April 18 and 19, 2023, from 9 a.m.
to 4:30 p.m., EDT. Written comments must be submitted by April 28,
2023. Registration to make oral comments must be submitted by April 4,
2023.
ADDRESSES: The telephone access number is 1-669-254-5252, Webinar ID:
160 343 1340, and the Passcode is 59009399. The web conference access
is <a href="https://cdc.zoomgov.com/j/1603431340?pwd=VnB3SmRrRFA0OWF2bUpVMGgzbW51QT09">https://cdc.zoomgov.com/j/1603431340?pwd=VnB3SmRrRFA0OWF2bUpVMGgzbW51QT09</a>, and the Passcode is
.6*m=vQb. The number of available audio and web conference lines is
1,000.
FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management
Lead, National Center for HIV, Viral Hepatitis, STD, and TB Prevention,
CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, Georgia 30329-4027;
Telephone: (404) 639-3423; Email: <a href="/cdn-cgi/l/email-protection#5739343f3f24232727383b3e342e1734333479303821"><span class="__cf_email__" data-cfemail="3b55585353484f4b4b54575258427b585f58155c544d">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis
and STD Prevention and Treatment (CHAC) is charged with advising the
Secretary of Health and Human Services, the Director, CDC, and the
Administrator, HRSA, regarding objectives, strategies, policies, and
priorities for HIV, viral hepatitis, and STD prevention and treatment
efforts including (1) surveillance; (2) epidemiologic, behavioral,
health services, and laboratory research; (3) identification of policy
issues and opportunities related to prevention and treatment including
but not limited to professional education, healthcare delivery, social
determinants of health, research, and prevention and treatment
services; (4) strategic issues influencing the ability of CDC and HRSA
to fulfill their missions; (5) development and implementation of
federal programs focused on prevention and treatment; and (6) provide
support to the agencies in their response to emerging health needs.
Matters To Be Considered: The agenda will include discussions on
(1) sexual health, (2) equitable scale-up of interventions, (3) mpox,
and (4) youth and STD testing. Agenda items are subject to change as
priorities dictate.
Public Participation
Written Public Comment: Members of the public are welcome to submit
written comments in advance of the meeting. Written comments must be
submitted by emailing <a href="/cdn-cgi/l/email-protection#2d434e45455e595d5d4241444e546d4e494e034a425b"><span class="__cf_email__" data-cfemail="4b25282323383f3b3b24272228320b282f28652c243d">[email protected]</span></a> with subject line ``Spring
CHAC Public Comment Registration'' by April 28, 2023.
Oral Public Comment: Individuals who would like to make an oral
comment during the public comment period must register by emailing
<a href="/cdn-cgi/l/email-protection#a9c7cac1c1daddd9d9c6c5c0cad0e9cacdca87cec6df"><span class="__cf_email__" data-cfemail="305e535858434440405f5c595349705354531e575f46">[email protected]</span></a> with subject line ``Spring CHAC Public Comment
Registration'' by April 4, 2023. The public comment period is on April
18, 2023, 3:45 p.m., EDT.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04044 Filed 2-27-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 28, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.